Human platelet thrombin receptors: Roles in platelet activation

Hematology/Oncology Clinics of North America

Volumn 14, Issue 5, 2000, Pages 1185-1198

  Ofosu, Frederick A ^a   Nyarko, Kwasi A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTERY THROMBOSIS; CELL PROLIFERATION; CYTOSKELETON; EMBRYO DEVELOPMENT; HEMOSTASIS; HUMAN; INFLAMMATION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTE SHAPE; WOUND HEALING;

EID: 0033832085     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70178-7     Document Type: Article

References (73)

1. Protease-activated receptor 1 is the primary mediator of thrombin stimulated platelet-procoagulant activity
2. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered ligand receptor
3. Development of potent thrombin receptor antagonist peptides
4. Protease-activated G protein-coupled receptor on human platelets and endothelial cells
5. Structure and function of the human platelet thrombin receptor: Studies using monoclonal antibodies against a defined epitope with the receptor N-terminus
6. Phosphatidylinositol 3,4,5-triphosphate is formed from phosphatidylinositol 4,5-biphosphate in thrombin-stimulated platelets
7. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of proto-oncogene product p95vav, in platelets
8. PAR-1 activation initiates integrin engagement and outside in signaling in megakaryoblastic CHRF-288 cells
9. Regulation of protein tyrosine kinases in platelets
10. Blockade of platelet-GPIIb/IIIa receptors as an antithrombotic strategy
11. Localization and characterization of an α-thrombin binding site on platelet glycoprotein Ib
12. Association of a phospholipase A (14-3-3 protein) with platelet glycoprotein Ib-IX complex
13. Thrombin bioregulatory functions
14. Understanding thrombosis and hemostasis
15. Platelet tyrosine-specific protein phosphorylation is regulated by thrombin
16. Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets
17. The biochemical pharmacology of thromboxane synthesis and inhibition in man
18. The cleaved peptide of the thrombin receptor is a strong platelet agonist
19. Regulation of platelets glycoprotein IIb/IIIa (integrin αIIbβ3) function via the thrombin receptor
20. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets
21. Role of platelet glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins
22. 2+], induced by α-thrombin
23. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands
24. Activation of platelets by α-thrombin is a receptor mediated event
25. Differential involvement of tyrosine and serine/threonine kinases in platelet integrin αIIbβ3 exposure
26. Internalization and recycling of activated thrombin receptors
27. 2+ activates phospholipase D in human platelets
28. Thrombin receptor-directed ligand accounts for activation of platelet phospholipase C and accumulation of phosphorylated phosphoinositides
29. Cloned platelet-thrombin receptor is necessary for thrombin-induced platelet activation
30. Cloned thrombin receptor complexes to at least 2 distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenyl cyclase
31. Protease-activated receptor 3 is a second thrombin receptor in humans
32. Non-receptor protein tyrosine kinases and phosphatases in human platelets
33. Pathophysiology of platelet thrombin receptors
34. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
35. A dual thrombin receptor for platelet activation
36. Granulocyte-platelet interactions and platelet fibrinogen exposure
37. 2 in human platelets
38. Biochemical mechanisms of platelet activation
39. Signal transduction induced by thrombin-activated platelets
40. Plasmin accelerates platelet-dependent prothrombinase assembly without activating the platelets
41. Binding of thrombin to the G-protein-linked receptor, and not to GPIb, precedes thrombin-mediated platelet activation
42. Thrombin binding to platelets and their activation in plasma
43. Thrombin receptor-activating peptide releases arachidonic acid from human platelets
44. + exchange via activation of thrombin receptor
45. Increased surface expression of membrane glycoprotein IIb/IIIa complex induced by platelet activation: Relationship between binding of fibrinogen and platelet aggregation
46. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: Evidence supporting receptor cleavage, release of the N-terminal peptide and insertion of the tethered ligand into a protected environment
47. A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction
48. Molecular cloning of a potential novel proteinase activated receptor
49. A trypsin-like platelet protease must release PAR-1 residues 1-41 and PAR-1 tethered ligand to optimize propagation of platelet activation
50. A trypsin-like protease propagates platelet PAR-1 cleavage and platelet activation
51. Activation of the fibrinogen receptor on human platelets exposed to α-chymotrypsin. Relationship to a major poteolytic cleavage at the carboxyl terminus of the membrane glycoprotein Ib heavy chain
52. Release of the thrombin receptor (PAR-1) N-terminus from the surface of human platelets activated by thrombin
53. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of thrombin
54. Specific inhibition of thrombin-induced cell activation by neutrophil proteinases elastase, cathepsin G, and proteinase 3: Evidence for distinct cleavage sites within the amino terminal domain of the thrombin receptor
55. Involvement of the 'tethered-ligand' receptor in thrombin inhibition of platelet adenyl cyclase
56. The occupancy of glycoprotein IIb/IIIa complex modulates thrombin activation of human platelets
57. 3 through cleavage of the carboxyl terminus of the α(IIb) subunit heavy chain
58. Antibodies to GPIIbα (300-312) inhibit fibrinogen binding, clot retraction, and platelet adhesion to multiple ligands
59. Prevention of cardiovascular ischemic complications with new platelet glycoprotein IIb/IIIa inhibitors
60. Phosphorylation and the affinity, state of platelet integrin αIIbβ3
61. Regulation of glycoprotein IIb/IIIa exposure on platelets stimulated with thrombin
62. Structure function relationships in the activation of platelet thrombin receptors by receptor-derived peptides
63. Accumulation of the inositol phosphates in thrombin-stimulated, washed rabbit platelets in the presence of lithium
64. Differences between platelet-phosphoinositide metabolism stimulated by thrombin SFLLRN are not accounted for by interaction of thrombin with glycoprotein Ib
65. Extraction of polyphosphoinositides from platelets
66. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
67. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses
68. Serine/threonine phosphatases
69. Resting platelets contain a substantial centrally located pool of glycoprotein IIb/IIIa complexes which may be accessible to some but not other extracellular proteins
70. Cloning and characterization of human protease-activated receptor 4
71. Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation
72. Phosphatidylinositol (3,4,5)-triphosphate stimulates phosphorylation of pleckstrin in human platelets